Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Cytochrome P450
Homo sapiens »
CYP1
CYP2
CYP3
CYP4
CYP5
CYP7
CYP8
CYP11
CYP17
CYP19
CYP20
CYP21
CYP24
CYP26
CYP27
CYP39
CYP46
CYP51
Mus musculus
Danio rerio
Oncorhynchus mykiss
Comparison of CYPs
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
FAQ
Contact Us
Versions
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
INDOMETHACIN
(1965)
Small molecule
Cyclooxygenase inhibitor
Unknown
Approved
Acute Pain; Arthralgia; Arthritis, Gouty; Arthritis, Rheumatoid; Cardiovascular Diseases; Ductus Arteriosus, Patent; Eye Diseases; Myalgia; Osteoarthritis; Rheumatic Diseases; Spondylitis; Spondylitis, Ankylosing
INDOMETHACIN
×
Maximum Phase:
4
First Approval:
1965
UNII:
XXE1CET956
Molecule Type:
Small molecule
Molecular Formula:
C19H16ClNO4
Molecular Weight:
357.79
AlogP:
3.93
PSA:
68.53
HBD:
1.0
HBA:
#RotB:
4.0
Source:
DOXAPRAM HYDROCHLORIDE
(1965)
Small molecule
Potassium channel subfamily K member 3 blocker
INJECTION
Approved
Lung Diseases
DOXAPRAM HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1965
UNII:
P5RU6UOQ5Y
Molecule Type:
Small molecule
Molecular Formula:
C24H33ClN2O3
Molecular Weight:
432.99
AlogP:
3.17
PSA:
32.78
HBD:
0.0
HBA:
#RotB:
6.0
Source:
PRILOCAINE
(1965)
Small molecule
Sodium channel alpha subunit blocker
Unknown
Approved
Pain
PRILOCAINE
×
Maximum Phase:
4
First Approval:
1965
UNII:
046O35D44R
Molecule Type:
Small molecule
Molecular Formula:
C13H20N2O
Molecular Weight:
220.32
AlogP:
2.32
PSA:
41.13
HBD:
2.0
HBA:
#RotB:
5.0
Source:
ETHIONAMIDE
(1965)
Small molecule
Enoyl-[acyl-carrier-protein] reductase inhibitor
ORAL
Approved
Tuberculosis
ETHIONAMIDE
×
Maximum Phase:
4
First Approval:
1965
UNII:
OAY8ORS3CQ
Molecule Type:
Small molecule
Molecular Formula:
C8H10N2S
Molecular Weight:
166.25
AlogP:
1.28
PSA:
38.91
HBD:
1.0
HBA:
#RotB:
2.0
Source:
FLURANDRENOLIDE
(1965)
Small molecule
Glucocorticoid receptor agonist
TOPICAL
Approved
Skin Diseases
FLURANDRENOLIDE
×
Maximum Phase:
4
First Approval:
1965
UNII:
8EUL29XUQT
Molecule Type:
Small molecule
Molecular Formula:
C24H33FO6
Molecular Weight:
436.52
AlogP:
2.5
PSA:
93.06
HBD:
2.0
HBA:
#RotB:
2.0
Source:
PRILOCAINE HYDROCHLORIDE
(1965)
Small molecule
Sodium channel alpha subunit blocker
INJECTION
Approved
Unknown
PRILOCAINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1965
UNII:
MJW015BAPH
Molecule Type:
Small molecule
Molecular Formula:
C13H21ClN2O
Molecular Weight:
256.78
AlogP:
2.32
PSA:
41.13
HBD:
2.0
HBA:
#RotB:
5.0
Source:
CHLORPHENESIN CARBAMATE
(1965)
Small molecule
Unknown
ORAL
Approved
Unknown
CHLORPHENESIN CARBAMATE
×
Maximum Phase:
4
First Approval:
1965
UNII:
57U5YI11WP
Molecule Type:
Small molecule
Molecular Formula:
C10H12ClNO4
Molecular Weight:
245.66
AlogP:
1.17
PSA:
81.78
HBD:
2.0
HBA:
#RotB:
5.0
Source:
OXAZEPAM
(1965)
Small molecule
GABA-A receptor; anion channel positive allosteric modulator
ORAL
Approved
Anxiety; Anxiety Disorders; Mental Disorders
OXAZEPAM
×
Maximum Phase:
4
First Approval:
1965
UNII:
6GOW6DWN2A
Molecule Type:
Small molecule
Molecular Formula:
C15H11ClN2O2
Molecular Weight:
286.72
AlogP:
2.45
PSA:
61.69
HBD:
2.0
HBA:
#RotB:
1.0
Source:
VINBLASTINE
(1965)
Small molecule
Unknown
Unknown
Approved
Neoplasms
VINBLASTINE
×
Maximum Phase:
4
First Approval:
1965
UNII:
5V9KLZ54CY
Molecule Type:
Small molecule
Molecular Formula:
C46H58N4O9
Molecular Weight:
810.99
AlogP:
3.99
PSA:
154.1
HBD:
3.0
HBA:
#RotB:
7.0
Source:
BETAMETHASONE SODIUM PHOSPHATE
(1965)
Small molecule
Glucocorticoid receptor agonist
INJECTION
Approved
Colitis, Ulcerative; Eye Diseases; Hemorrhoids; Lung Diseases, Obstructive; Nasal Obstruction
BETAMETHASONE SODIUM PHOSPHATE
×
Maximum Phase:
4
First Approval:
1965
UNII:
7BK02SCL3W
Molecule Type:
Small molecule
Molecular Formula:
C22H28FNa2O8P
Molecular Weight:
516.41
AlogP:
2.01
PSA:
141.36
HBD:
4.0
HBA:
#RotB:
4.0
Source:
AMPICILLIN
(1965)
Small molecule
Bacterial penicillin-binding protein inhibitor
Unknown
Approved
Bacterial Infections; Eye Infections; Gonorrhea; Infections; Meningitis; Meningitis, Bacterial
AMPICILLIN
×
Maximum Phase:
4
First Approval:
1965
UNII:
7C782967RD
Molecule Type:
Small molecule
Molecular Formula:
C16H19N3O4S
Molecular Weight:
349.41
AlogP:
0.32
PSA:
112.73
HBD:
3.0
HBA:
#RotB:
4.0
Source:
BETAMETHASONE ACETATE
(1965)
Small molecule
Glucocorticoid receptor agonist
Unknown
Approved
Anemia; Asthma; Colitis, Ulcerative; Dermatitis; Eye Diseases; Hemorrhoids; Lung Diseases, Obstructive; Nasal Obstruction; Nephrotic Syndrome; Serum Sickness
BETAMETHASONE ACETATE
×
Maximum Phase:
4
First Approval:
1965
UNII:
TI05AO53L7
Molecule Type:
Small molecule
Molecular Formula:
C24H31FO6
Molecular Weight:
434.5
AlogP:
2.47
PSA:
100.9
HBD:
2.0
HBA:
#RotB:
3.0
Source:
EPINEPHRINE BITARTRATE
(1965)
Small molecule
Adrenergic receptor agonist
INHALATION
Approved
Pain
EPINEPHRINE BITARTRATE
×
Maximum Phase:
4
First Approval:
1965
UNII:
30Q7KI53AK
Molecule Type:
Small molecule
Molecular Formula:
C13H19NO9
Molecular Weight:
333.29
AlogP:
0.35
PSA:
72.72
HBD:
4.0
HBA:
#RotB:
3.0
Source:
NAFCILLIN
(1965)
Small molecule
Unknown
Unknown
Approved
Bacterial Infections
NAFCILLIN
×
Maximum Phase:
4
First Approval:
1965
UNII:
4CNZ27M7RV
Molecule Type:
Small molecule
Molecular Formula:
C21H22N2O5S
Molecular Weight:
414.48
AlogP:
2.48
PSA:
95.94
HBD:
2.0
HBA:
#RotB:
5.0
Source:
NAFCILLIN SODIUM
(1965)
Small molecule
Penicillin-binding protein inhibitor
INJECTION; ORAL
Approved
Infections
NAFCILLIN SODIUM
×
Maximum Phase:
4
First Approval:
1965
UNII:
49G3001BCK
Molecule Type:
Small molecule
Molecular Formula:
C21H23N2NaO6S
Molecular Weight:
454.48
AlogP:
2.48
PSA:
95.94
HBD:
2.0
HBA:
#RotB:
5.0
Source:
THIOGUANINE
(1966)
Small molecule
DNA inhibitor
ORAL
Approved
Neoplasms
THIOGUANINE
×
Maximum Phase:
4
First Approval:
1966
UNII:
FTK8U1GZNX
Molecule Type:
Small molecule
Molecular Formula:
C5H5N5S
Molecular Weight:
167.2
AlogP:
0.6
PSA:
83.38
HBD:
3.0
HBA:
#RotB:
0.0
Source:
ETHYNODIOL DIACETATE
(1966)
Small molecule
Progesterone receptor agonist
Unknown
Approved
Unknown
ETHYNODIOL DIACETATE
×
Maximum Phase:
4
First Approval:
1966
UNII:
62H10A1236
Molecule Type:
Small molecule
Molecular Formula:
C24H32O4
Molecular Weight:
384.52
AlogP:
4.43
PSA:
52.6
HBD:
0.0
HBA:
#RotB:
2.0
Source:
FUROSEMIDE
(1966)
Small molecule
Sodium-(potassium)-chloride cotransporter 2 inhibitor
INJECTION; ORAL
Approved
Cardiovascular Diseases; Fibrosis; Heart Failure; Hypertension; Liver Cirrhosis; Nephrotic Syndrome; Pulmonary Edema; Syndrome
FUROSEMIDE
×
Maximum Phase:
4
First Approval:
1966
UNII:
7LXU5N7ZO5
Molecule Type:
Small molecule
Molecular Formula:
C12H11ClN2O5S
Molecular Weight:
330.75
AlogP:
1.89
PSA:
122.63
HBD:
3.0
HBA:
#RotB:
5.0
Source:
PIPOBROMAN
(1966)
Small molecule
DNA inhibitor
ORAL
Approved
Neoplasms
PIPOBROMAN
×
Maximum Phase:
4
First Approval:
1966
UNII:
6Q99RDT97R
Molecule Type:
Small molecule
Molecular Formula:
C10H16Br2N2O2
Molecular Weight:
356.06
AlogP:
1.23
PSA:
40.62
HBD:
0.0
HBA:
#RotB:
4.0
Source:
TOLAZAMIDE
(1966)
Small molecule
Sulfonylurea receptor 1, Kir6.2 blocker
ORAL
Approved
Diabetes Mellitus; Diabetes Mellitus, Type 2
TOLAZAMIDE
×
Maximum Phase:
4
First Approval:
1966
UNII:
9LT1BRO48Q
Molecule Type:
Small molecule
Molecular Formula:
C14H21N3O3S
Molecular Weight:
311.41
AlogP:
1.77
PSA:
78.51
HBD:
2.0
HBA:
#RotB:
3.0
Source:
ALLOPURINOL
(1966)
Small molecule
Xanthine dehydrogenase inhibitor
ORAL
Approved
Gout; Leukemia; Lymphoma; Neoplasms; Response Evaluation Criteria in Solid Tumors
ALLOPURINOL
×
Maximum Phase:
4
First Approval:
1966
UNII:
63CZ7GJN5I
Molecule Type:
Small molecule
Molecular Formula:
C5H4N4O
Molecular Weight:
136.11
AlogP:
-0.4
PSA:
74.43
HBD:
2.0
HBA:
#RotB:
0.0
Source:
SULFAMETER
(1966)
Small molecule
Bacterial dihydropteroate synthase inhibitor
ORAL
Approved
Bacterial Infections
SULFAMETER
×
Maximum Phase:
4
First Approval:
1966
UNII:
3L179F09D6
Molecule Type:
Small molecule
Molecular Formula:
C11H12N4O3S
Molecular Weight:
280.31
AlogP:
0.87
PSA:
107.2
HBD:
2.0
HBA:
#RotB:
4.0
Source:
HALOPERIDOL
(1967)
Small molecule
D2-like dopamine receptor inverse agonist
INJECTION; ORAL
Approved
Conduct Disorder; Psychotic Disorders; Schizophrenia; Tics; Tourette Syndrome
HALOPERIDOL
×
Maximum Phase:
4
First Approval:
1967
UNII:
J6292F8L3D
Molecule Type:
Small molecule
Molecular Formula:
C21H23ClFNO2
Molecular Weight:
375.87
AlogP:
4.43
PSA:
40.54
HBD:
1.0
HBA:
#RotB:
6.0
Source:
THIABENDAZOLE
(1967)
Small molecule
Tubulin inhibitor
ORAL
Approved
Helminthiasis
THIABENDAZOLE
×
Maximum Phase:
4
First Approval:
1967
UNII:
N1Q45E87DT
Molecule Type:
Small molecule
Molecular Formula:
C10H7N3S
Molecular Weight:
201.25
AlogP:
2.69
PSA:
41.57
HBD:
1.0
HBA:
#RotB:
1.0
Source:
METHENAMINE
(1967)
Small molecule
Unknown
Unknown
Approved
Bacterial Infections
METHENAMINE
×
Maximum Phase:
4
First Approval:
1967
UNII:
J50OIX95QV
Molecule Type:
Small molecule
Molecular Formula:
C6H12N4
Molecular Weight:
140.19
AlogP:
-1.02
PSA:
12.96
HBD:
0.0
HBA:
#RotB:
0.0
Source:
CLOMIPHENE
(1967)
Small molecule
Unknown
Unknown
Approved
Unknown
CLOMIPHENE
×
Maximum Phase:
4
First Approval:
1967
UNII:
1HRS458QU2
Molecule Type:
Small molecule
Molecular Formula:
C26H28ClNO
Molecular Weight:
405.97
AlogP:
6.56
PSA:
12.47
HBD:
0.0
HBA:
#RotB:
9.0
Source:
DOXYCYCLINE
(1967)
Small molecule
Bacterial 70S ribosome inhibitor
ORAL
Approved
Acne Vulgaris; Anthrax; Bacterial Infections; Brucellosis; Cholera; Gonorrhea; Infections; Malaria; Periodontitis; Pneumonia; Psittacosis; Rocky Mountain Spotted Fever; Rosacea; Spotted Fever Group Rickettsiosis; Tularemia; Typhus, Epidemic Louse-Borne
DOXYCYCLINE
×
Maximum Phase:
4
First Approval:
1967
UNII:
N12000U13O
Molecule Type:
Small molecule
Molecular Formula:
C22H26N2O9
Molecular Weight:
462.46
AlogP:
-0.35
PSA:
181.62
HBD:
6.0
HBA:
#RotB:
2.0
Source:
ETHAMBUTOL HYDROCHLORIDE
(1967)
Small molecule
Arabinosyltransferase A inhibitor
ORAL
Approved
Tuberculosis; Tuberculosis, Pulmonary
ETHAMBUTOL HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1967
UNII:
QE4VW5FO07
Molecule Type:
Small molecule
Molecular Formula:
C10H26Cl2N2O2
Molecular Weight:
277.24
AlogP:
-0.29
PSA:
64.52
HBD:
4.0
HBA:
#RotB:
9.0
Source:
PROTRIPTYLINE HYDROCHLORIDE
(1967)
Small molecule
Norepinephrine transporter inhibitor
ORAL
Approved
Depressive Disorder
PROTRIPTYLINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1967
UNII:
44665V00O8
Molecule Type:
Small molecule
Molecular Formula:
C19H22ClN
Molecular Weight:
299.85
AlogP:
4.3
PSA:
12.03
HBD:
1.0
HBA:
#RotB:
4.0
Source:
CLOFIBRATE
(1967)
Small molecule
Peroxisome proliferator-activated receptor alpha agonist
ORAL
Approved
Cardiovascular Diseases
CLOFIBRATE
×
Maximum Phase:
4
First Approval:
1967
UNII:
HPN91K7FU3
Molecule Type:
Small molecule
Molecular Formula:
C12H15ClO3
Molecular Weight:
242.7
AlogP:
3.06
PSA:
35.53
HBD:
0.0
HBA:
#RotB:
4.0
Source:
ERYTHROMYCIN ESTOLATE
(1967)
Small molecule
Bacterial 70S ribosome inhibitor
ORAL
Approved
Unknown
ERYTHROMYCIN ESTOLATE
×
Maximum Phase:
4
First Approval:
1967
UNII:
XRJ2P631HP
Molecule Type:
Small molecule
Molecular Formula:
C52H97NO18S
Molecular Weight:
1056.4
AlogP:
2.75
PSA:
199.98
HBD:
4.0
HBA:
#RotB:
9.0
Source:
DOXYCYCLINE HYCLATE
(1967)
Small molecule
Bacterial 70S ribosome inhibitor
INJECTION; ORAL; PERIODONTAL
Approved
Acne Vulgaris
DOXYCYCLINE HYCLATE
×
Maximum Phase:
4
First Approval:
1967
UNII:
19XTS3T51U
Molecule Type:
Small molecule
Molecular Formula:
C46H58Cl2N4O18
Molecular Weight:
1025.89
AlogP:
-0.35
PSA:
181.62
HBD:
6.0
HBA:
#RotB:
2.0
Source:
METHENAMINE HIPPURATE
(1967)
Small molecule
DNA inhibitor
ORAL
Approved
Infections; Urinary Tract Infections
METHENAMINE HIPPURATE
×
Maximum Phase:
4
First Approval:
1967
UNII:
M329791L57
Molecule Type:
Small molecule
Molecular Formula:
C15H21N5O3
Molecular Weight:
319.37
AlogP:
-1.02
PSA:
12.96
HBD:
0.0
HBA:
#RotB:
0.0
Source:
ETHAMBUTOL
(1967)
Small molecule
Unknown
Unknown
Approved
Tuberculosis
ETHAMBUTOL
×
Maximum Phase:
4
First Approval:
1967
UNII:
8G167061QZ
Molecule Type:
Small molecule
Molecular Formula:
C10H24N2O2
Molecular Weight:
204.31
AlogP:
-0.29
PSA:
64.52
HBD:
4.0
HBA:
#RotB:
9.0
Source:
MEFENAMIC ACID
(1967)
Small molecule
Cyclooxygenase inhibitor
ORAL
Approved
Dysmenorrhea; Rheumatic Diseases
MEFENAMIC ACID
×
Maximum Phase:
4
First Approval:
1967
UNII:
367589PJ2C
Molecule Type:
Small molecule
Molecular Formula:
C15H15NO2
Molecular Weight:
241.29
AlogP:
3.75
PSA:
49.33
HBD:
2.0
HBA:
#RotB:
3.0
Source:
PROPRANOLOL
(1967)
Small molecule
Unknown
Unknown
Approved
Cardiovascular Diseases
PROPRANOLOL
×
Maximum Phase:
4
First Approval:
1967
UNII:
9Y8NXQ24VQ
Molecule Type:
Small molecule
Molecular Formula:
C16H21NO2
Molecular Weight:
259.35
AlogP:
2.58
PSA:
41.49
HBD:
2.0
HBA:
#RotB:
6.0
Source:
1
2
…
11
12
13
14
15
16
17
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA